
Dual incretin control. Single compound.
Tirzepatide — the GIP/GLP-1 dual agonist for appetite, glucose, and body composition.
Dual Melt is a Tirzepatide protocol, a dual GIP and GLP-1 receptor agonist designed for powerful appetite control, glycemic improvement, and metabolic recomposition.
Tirzepatide activates both GIP and GLP-1 receptors to enhance glucose-dependent insulin secretion, slow gastric emptying, and amplify central satiety signals.
2.5 mg subcutaneous weekly to start, titrating in 2.5 mg increments every 4 weeks as tolerated. 12-week cycle minimum.
Weekly subcutaneous injection into the abdomen, thigh, or upper arm. Rotate sites each week.
Refrigerate at 2–8 °C. Do not freeze.
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.
MetabolicSLU-PP-332 AMPK activator that mimics the metabolic signature of endurance training.
MetabolicRetatrutide 50mg/3mL — triple agonist of GLP-1, GIP, and Glucagon receptors.
MetabolicTirzepatide 60mg/3mL — GLP-1 / GIP dual agonist for advanced fat loss.
MetabolicPre-filled 60mg/3ml MOTS-c pen — mitochondrially encoded peptide that boosts metabolic flexibility.